Moderna Europe — Property, plant and equipment, net increased by 7.1% to $303.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.1%, from $283.00M to $303.00M.
An increase suggests capital expansion or investment in local production capacity, while a decrease may signal asset depreciation, divestment, or a shift toward outsourcing.
This metric represents the net book value of tangible long-term assets located within the European segment, including ma...
Comparable to regional asset disclosures in 10-K filings for global life sciences companies, reflecting the scale of regional supply chain and R&D infrastructure.
mrna_segment_europe_property_plant_and_equipment_net| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $181.00M | $714.00M | $126.00M | $283.00M | $303.00M |
| QoQ Change | — | +294.5% | -82.4% | +124.6% | +7.1% |
| YoY Change | — | +294.5% | -82.4% | +124.6% | +7.1% |